Top Markets
#1 Akedo Akedo +59.32%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.39%
#4 Velvet Velvet +43.06%
#5 Black Phoenix Black Phoenix +34.58%
#6 τemplar τemplar +22.94%
#7 Cap Cap +19.28%
#8 Ribbita by Virtuals Ribbita by Virtuals +17.53%
#9 Cross Cross +17.30%
#10 Bitway Bitway +15.59%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
CohBar, Inc. CohBar, Inc.

CohBar, Inc.

CWBR
Classement en actions #38304
CohBar Inc. is a clinical-stage biotechnology company dedicated to the... CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum of medical challenges, including non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis (IPF), type 2 diabetes, acute respiratory distress syndrome (ARDS), various cancers, and cardiovascular disorders like Alzheimer's disease. Their flagship clinical asset is CB4211, an innovative, optimized analogue of the MOTS-c mitochondrial-derived peptide. This candidate is currently undergoing Phase Ib evaluation as part of a larger Phase Ia/Ib clinical trial, specifically targeting non-alcoholic steatohepatitis (NASH) and obesity. Beyond their clinical work, CohBar's preclinical portfolio features CB5138 analogs aimed at fibrotic conditions, as well as CB5064 analogs being explored for their potential in treating ARDS linked to COVID-19. Established in 2007, CohBar, Inc. maintains its corporate headquarters in Menlo Park, California.
Prix de l'action
$0.41
Dernière synchronisation: 2025-01-23
Capitalisation boursière
$1.08M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange CohBar, Inc. (CWBR)

Catégorie

Healthcare
Nombre d'actions en circulation pour CohBar, Inc. (CWBR)
Nombre d'actions en circulation au June 2023: 2.91M
Selon les derniers rapports financiers et le cours de l'action de CohBar, Inc., le nombre actuel d'actions en circulation est de 2.91M. À la fin de December 2021, l'entreprise avait 2.22M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de CohBar, Inc. (CWBR) de 2012 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
2026 (TTM) 2.91M 0.31%
2022 2.90M 30.54%
2021 2.22M 36.45%
2020 1.63M 14.02%
2019 1.43M 3.78%
2018 1.38M 10.09%
2017 1.25M 13.13%
2016 1.10M 3.37%
2015 1.07M 80.48%
2014 591.75K 37.62%
2013 430.00K 6.70%
2012 403.00K 0.00%
Actions en circulation pour des entreprises similaires ou concurrentes
Entreprise Actions en circulation Différence Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 8,634.31%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 2,039.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE